Zobrazeno 1 - 10
of 129
pro vyhledávání: '"S M, Alavian"'
Autor:
Sasan Sanjari Pirayvatlou, Madjad Einollahi, Pouyan Sanjari Pirayvatlou, Peyman Sanjari Pirayvatlou, S M Alavian, Mina Mahboodi
Publikováno v:
Journal of Pharmaceutical Research International. :1-10
Context: HCV infection in patients with chronic kidney disease (CKD) is important to be treated because it's associated with increased healthcare costs, utilization and is pertained with decrease in survival rate of HCV-infected patients who also hav
Autor:
B. Einollahi, S. M. Alavian, M. Lessan-Pezeshki, N. Simforoosh, M. H. Nourbala, Z. Rostami, V. Pourfarziani, E. Nemati, M. Sharafi, M. Nafar, F. Pour-Reza Gholi, A. Firoozan
Publikováno v:
International Journal of Organ Transplantation Medicine, Vol 1, Iss 2, Pp 91-93 (2010)
Background: With the success of kidney transplantation, liver disease has emerged as an important cause of morbidity and mortality in kidney recipients.Objective: To determine the impact of hepatitis B virus (HBV) infection on patients and graft surv
Externí odkaz:
https://doaj.org/article/f3fbb10a80184661b052d53b353abcda
Publikováno v:
Porto biomedical journal. 2(5)
Publikováno v:
Молекулярная биология. 50:279-283
Autor:
V. Liakina, S. Hamid, J. Tanaka, S. Olafsson, A. I. Sharara, S. M. Alavian, L. Gheorghe, E. S. El Hassan, F. Abaalkhail, Z. Abbas, A. Abdou, A. Abourached, F. Al Braiki, F. Al Hosani, K. Al Jaberi, M. Al Khatry, M. A. Al Mulla, H. Al Quraishi, A. Al Rifai, Y. Al Serkal, A. Alam, H. I. Alashgar, S. Alawadhi, L. Al-Dabal, P. Aldins, F. Z. Alfaleh, A. S. Alghamdi, R. Al-Hakeem, A. A. Aljumah, A. Almessabi, A. N. Alqutub, K. A. Alswat, I. Altraif, M. Alzaabi, N. Andrea, A. M. Assiri, M. A. Babatin, A. Baqir, M. T. Barakat, O. M. Bergmann, A. R. Bizri, S. Blach, A. Chaudhry, M. S. Choi, T. Diab, S. Djauzi, S. El Khoury, C. Estes, S. Fakhry, J. I. Farooqi, H. Fridjonsdottir, R. A. Gani, A. Ghafoor Khan, A. Goldis, M. Gottfredsson, S. Gregorcic, B. Hajarizadeh, K. H. Han, I. Hasan, A. Hashim, G. Horvath, B. Hunyady, R. Husni, W. Jafri, A. Jeruma, J.G. Jonasson, B. Karlsdottir, D. Y. Kim, Y. S. Kim, Z. Koutoubi, L. A. Lesmana, Y. S. Lim, A. Löve, M. Maimets, M. Makara, R. Malekzadeh, M. Matičič, M. S. Memon, S. Merat, J. E. Mokhbat, F. H. Mourad, D. H. Muljono, A. Nawaz, N. Nugrahini, S. Priohutomo, H. Qureshi, P. Rassam, H. Razavi, D. Razavi-Shearer, K. Razavi-Shearer, B. Rozentale, M. Sadik, K. Saeed, A. Salamat, R. Salupere, F. M. Sanai, A. Sanityoso Sulaiman, R. A. Sayegh, J. D. Schmelzer, A. Sibley, M. Siddiq, A. M. Siddiqui, G. Sigmundsdottir, B. Sigurdardottir, D. Speiciene, A. Sulaiman, M. A. Sultan, M. Taha, H. Tarifi, G. Tayyab, I. Tolmane, M. Ud din, M. Umar, J. Valantinas, J. Videčnik-Zorman, C. Yaghi, E. Yunihastuti, M. A. Yusuf, B. F. Zuberi, J. Gunter
Detailed, country‐specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider nat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cd6e7288125599acfb8ef6dcd855e4f
https://zenodo.org/record/2682677
https://zenodo.org/record/2682677
Autor:
A. Sibley, K. H. Han, A. Abourached, L. A. Lesmana, M. Makara, W. Jafri, R. Salupere, A. M. Assiri, A. Goldis, F. Abaalkhail, Z. Abbas, A. Abdou, F. Al Braiki, F. Al Hosani, K. Al Jaberi, M. Al Khatry, M. A. Al Mulla, H. Al Quraishi, A. Al Rifai, Y. Al Serkal, A. Alam, S. M. Alavian, H. I. Alashgar, S. Alawadhi, L. Al-Dabal, P. Aldins, F. Z. Alfaleh, A. S. Alghamdi, R. Al-Hakeem, A. A. Aljumah, A. Almessabi, A. N. Alqutub, K. A. Alswat, I. Altraif, M. Alzaabi, N. Andrea, M. A. Babatin, A. Baqir, M. T. Barakat, O. M. Bergmann, A. R. Bizri, S. Blach, A. Chaudhry, M. S. Choi, T. Diab, S. Djauzi, E. S. El Hassan, S. El Khoury, C. Estes, S. Fakhry, J. I. Farooqi, H. Fridjonsdottir, R. A. Gani, A. Ghafoor Khan, L. Gheorghe, M. Gottfredsson, S. Gregorcic, J. Gunter, B. Hajarizadeh, S. Hamid, I. Hasan, A. Hashim, G. Horvath, B. Hunyady, R. Husni, A. Jeruma, J. G. Jonasson, B. Karlsdottir, D. Y. Kim, Y. S. Kim, Z. Koutoubi, V. Liakina, Y. S. Lim, A. Löve, M. Maimets, R. Malekzadeh, M. Matičič, M. S. Memon, S. Merat, J. E. Mokhbat, F. H. Mourad, D. H. Muljono, A. Nawaz, N. Nugrahini, S. Olafsson, S. Priohutomo, H. Qureshi, P. Rassam, H. Razavi, D. Razavi-Shearer, K. Razavi-Shearer, B. Rozentale, M. Sadik, K. Saeed, A. Salamat, F. M. Sanai, A. Sanityoso Sulaiman, R. A. Sayegh, A. I. Sharara, M. Siddiq, A. M. Siddiqui, G. Sigmundsdottir, B. Sigurdardottir, D. Speiciene, A. Sulaiman, M. A. Sultan, M. Taha, J. Tanaka, H. Tarifi, G. Tayyab, I. Tolmane, M. Ud din, M. Umar, J. Valantinas, J. Videčnik-Zorman, C. Yaghi, E. Yunihastuti, M. A. Yusuf, B. F. Zuberi, J. D. Schmelzer
Publikováno v:
Journal of viral hepatitis. 22
The total number, morbidity and mortality attributed to viraemic hepatitis C virus (HCV) infections change over time making it difficult to compare reported estimates from different years. Models were developed for 15 countries to quantify and charac
Autor:
Yousef Yahyapour, Vahdat Poortahmasebi, Michael Roggendorf, Seyed Mohammad Jazayeri, Sajad Shahmoradi, S M Alavian, Hadi Karimzadeh, Ahmadreza Sadeghi
Publikováno v:
Journal of viral hepatitis. 23(4)
In a previous study, we observed immunoprophylaxis failure due to occult hepatitis B virus (HBV) infection (OBI) despite the presence of adequate levels of anti-HBs in 21 (28%) of 75 children born to HBsAg-positive mothers. The aim of the study was t
Publikováno v:
Molekuliarnaia biologiia. 50(2)
MicroRNAs (miRNAs) are small non-coding RNA molecules, which have an important function in regulating RNA stability and gene expression. They also can circulate in a cell-free form in the blood thatmakes them potential disease markers. The liver cont
Autor:
B, Einollahi, S M, Alavian, M, Lessan-Pezeshki, N, Simforoosh, M H, Nourbala, Z, Rostami, V, Pourfarziani, E, Nemati, M, Sharafi, M, Nafar, F, Pour-Reza Gholi, A, Firoozan
Publikováno v:
International Journal of Organ Transplantation Medicine
Background: With the success of kidney transplantation, liver disease has emerged as an important cause of morbidity and mortality in kidney recipients. Objective: To determine the impact of hepatitis B virus (HBV) infection on patients and graft sur
Autor:
M, Keshvari, S M, Alavian, B, Aghaee, B, Behnava, M, Mahdavi, M Gholami, Fesharaki, H, Sharafi
Publikováno v:
Transfusion medicine (Oxford, England). 24(6)
Hepatitis B is a significant health problem and more than 350 million individuals are infected with hepatitis B virus (HBV) globally. About 5% of these individuals are coinfected with hepatitis D virus (HDV). HBV-HDV coinfection increases the rate of